Not Tagged
Not Tagged
['sarcoma', 'reecur']
high-dose ifosfamide has shown superior survival benefit over three other chemotherapy regimens for patients with recurring or refractory primary ewing sarcoma in the practice-changing reecur trial at #asco22. 
Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.